Thrombotic risk factors in nonmalignant and noncirrhotic patients with portal vein thrombosis: need for extensive investigation

Eur J Gastroenterol Hepatol. 2016 Jan;28(1):116-8. doi: 10.1097/MEG.0000000000000501.

Authors

Admir Kurtcehajic¹, Enver Zerem, Ahmed Hujdurovic, Jasmin A Fejzic

Affiliation

¹ aDepartment of Internal Medicine, Medical Center 'Plava Poliklinika' Tuzla bDepartment of Gastroenterology and Hepatology, University Clinical Center Tuzla, Tuzla cDepartment of Medical Sciences, The Academy of Sciences and Arts of Bosnia and Herzegovina, Sarajevo dDepartment of Internal Medicine, General Hospital Tesanj, Tesanj, Bosnia and Herzegovina.

PMID: 26594916
DOI: 10.1097/MEG.0000000000000501

No abstract available

Publication types

Letter
Comment

MeSH terms

Female
Humans
Hyperhomocysteinemia / complications*
Janus Kinase 2 / genetics*
Male
Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
Myeloproliferative Disorders / complications*
Portal Vein*
Venous Thrombosis / etiology*

Substances

Methylenetetrahydrofolate Reductase (NADPH2)
Janus Kinase 2